The MTPConnect Podcast

Jeff Gibbs is a Director at Hyman Phelps and McNamara – the largest law firm specialising in FDA issues, based in Washington DC. With four decades of FDA expertise he delivers crucial insights for medical technology companies aiming to crack the US market. Peaking to the podcast during his national tour for the MTPConnect seminar series, this US-based regulatory veteran shares his strategic tips on the FDA submission process, and d...

Medical Alley is a powerhouse in global healthcare innovation, connecting startups and Fortune 100 companies to transform healthcare solutions. Headquartered in Minnesota, it’s one of the world’s largest medtech clusters.

At the 2024 MedTech Conference in Canada, MTPConnect and Medical Alley renewed an MOU to strengthen collaboration and support for Australian medtech companies looking to expand internationally.

Now, Medical Alley is...

Dive into another episode coming to you from MTPConnect’s Development Workshop Series held recently in Sydney for 52 start-up organisations from around Australia. The 2-day program was a terrific opportunity for companies participating in our Accelerator programs to get ‘investor ready’.

Exportia Australia’s Christelle Damiens, an entrepreneur and award-winning author, shared her insights in the workshop “Accessing Global Markets”. ...

This episode is coming to you from MTPConnect’s Development Workshop Series held in Sydney for 52 start-up organisations from around Australia. The 2-day program was a terrific opportunity for companies participating in our Accelerator programs to get ‘investor ready’.

Advisory firm Intrinsika’s workshop, ‘Finding Your Intrinsic Value’, focused on how to reframe a company’s value beyond the financials, by identifying and maximising ...

The Australian Stroke and Heart Research Accelerator, established through MTPConnect’s Targeted Translation Research Accelerator for cardiovascular disease and diabetes on behalf the Medical Research Future Fund, is a research centre with a bold vision to deliver new health outcomes in coronary artery disease, heart failure and stroke.

Through clinical impact and entrepreneurship, an Australian wide network of academics, institution...

We meet Dr Daniel Timms, the Australian biomechanical engineer behind BiVACOR who has dedicated his life to developing a titanium Total Artificial Heart (TAH) to restore the lives of people with end-stage heart failure, a disease that impacted his own family.

It’s a 25-year quest that has taken him from a PhD at QUT, developing the device with his father in his parent’s kitchen in Queensland, to collaborating with experts around the...

As World Antimicrobial Resistance Awareness Week (WAAW) kicked off around the globe, the Australian Antimicrobial Resistance Network (AAMRNet) was meeting in Canberra to explore how Australia can better support the development of and access to new antimicrobial technologies. 

Key clinicians, researchers, industry and government representatives gathered to discuss how a subscription-style funding model for new antimicrobials might be...

It’s World Antimicrobial Resistance Awareness Week (WAAW) and the theme is "Educate. Advocate. Act now". It’s a yearly global campaign, raising awareness of antimicrobial resistance (AMR) and promoting ways to reduce the spread of drug-resistant infections. 

To mark the occasion, MTPConnect’s Andrew Bowskill, Co-chair of the Australian Antimicrobial Resistance Network, AAMRNet, and Anne Harris, Managing Director of Pfizer ...

As thousands in the medical technology sector headed to Toronto, Canada for The MedTech 2024 Conference, MTPConnect was making sure that the 18 companies and organisations joining the Australian delegation were given opportunities to showcase their capabilities and make valuable US and international connections with a stopover in the medtech hub of Minnesota, before hitting Toronto.

In this podcast special from North America, our MT...

In July 2024, MTPConnect was selected to deliver a new $28.5 million investment for Drugs and Devices, which builds on the legacy of the inaugural TTRA program.

The objective of TTRA Drugs and Devices is to accelerate development and commercialisation of promising drugs and medical devices into products that can reduce the burden of cardiovascular disease and complications of diabetes for patients, carers, families and com...

Omico is leading Australia’s largest cancer genomics initiative –giving 23,000 Australians nationwide with advanced or incurable cancers, access to genomic profiling to detect unique genetic variations in their tumours to identify potential matches to new targeted treatments options. It is opening up new treatment pathways, extending lives and attracting more international trials to Australia.

Professor David Thomas, renowned for hi...

Biocom California is the US state’s advocate for the life sciences industry with a network of over 1700 members. With offices located in San Diego, Los Angeles, San Francisco Bay Area, Sacramento, Washington, D.C, and Tokyo the group is focused on building international collaborations and networks to bring new medicines to patients.

MTPConnect recently signed an MoU with Biocom California during a visit to San Diego for the 2024 BIO...

Back in June, MTPConnect led the Australian delegation at BIO 2024 in San Diego organising a range of activities to showcase Australia’s innovative life sciences sector to the international biotech industry. With a powerful #TeamAustralia focus and a 500-strong delegation from Australia, BIO2024 was the biggest and best ever! 

In this BIO Bites episode, hosts Caroline Duell and Stuart Dignam catch up with Australian and global compa...

Back in June, MTPConnect led the Australian delegation at BIO 2024 in San Diego organising a range of activities to showcase Australia’s innovative life sciences sector to the international biotech industry. With a powerful #TeamAustralia focus and a 500-strong delegation from Australia, BIO2024 was the biggest and best ever! 

In this BIO Bites episode, hosts Caroline Duell and Stuart Dignam catch up with Australian and global compa...

Diabetes affects one in 20 people. An important initiative to set up a ‘virtual’ emergency department designed for people living with diabetes has launched in Melbourne, Victoria during National Diabetes Week, with the aim of preventing unnecessary trips to hospital. 

The Victorian Virtual Emergency Department-Diabetes Service will be added to the existing Victorian Virtual Emergency Department (VVED) giving patients 24/7 online vi...

ARM Hub is a technology adoption hub based in Brisbane, with a focus on robotics, AI and design for manufacture for biomedical, energy and defence industries.

The not for profit was recently appointed as one of four AI Adopt Centres by the Government to provide a service for SMEs that demonstrates how data and AI can modernise business, build skills and boost productivity. ARM Hub is also leading the Australian Manufacturing Capabil...

The Clinical Translation and Commercialisation Medtech (CTCM) program aims to boost commercialisation of home-grown medical products. It is delivered by MTPConnect on behalf of the Medical Research Future Fund.

WA-based VitalTrace is one of the companies participating in the CTCM program and developing a groundbreaking medical device to revolutionise fetal monitoring during childbirth. The company has set up an Australian-based man...

Back in 2022, the Government of Western Australia issued a global challenge for a world-leading medical research and innovation solution to resolve a pressing problem of health service delivery in the remote Pilbara region.

Ten projects were selected as finalists and given 12 months proof of concept funding to deliver their solution on the ground in the Pilbara. With the competition ending in October, the best solution wil...

The Australian Stroke & Heart Research Accelerator (ASHRA) was established in early 2022 as part of the Targeted Translation Research Accelerator – a program delivered by MTPConnect for the Medical Research Future Fund.

This is a research centre with a difference. Lead by Australia’s foremost heart and stroke researchers, ASHRA is aiming to transform the field of cardiovascular and stroke research in Australia by bring...